Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal Indonesian Journal of Urology Journal of Midwifery
Zulfiqar, Yefri
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
COMPARISON OF THE EFFECTIVENESS OF EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) AND TADALAFIL ON ORGANIC ERECTILE DYSFUNCTION Wiradinata, Indra; Zulfiqar, Yefri; Myh, Etriyel; Hardisman
Indonesian Journal of Urology Vol 27 No 1 (2020)
Publisher : Indonesian Urological Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32421/juri.v27i1.484

Abstract

Objective: To find a comparison of the effectiveness of ESWT and Tadalafil on organic erectile dysfunction. Material & Methods: This is a Quasi Experiment study that was carried out from February 2018 to April 2018. ESWT treatment was performed in Urology Outpatient Clinic. Cialis 10 mg was used in cased of Tadalafil. The sample size is 40 patients consists of 20 patients each treatment. The data was processed with a significance limit of p<0.05. Results: The sample age average is 61.7 years, the level of total cholesterol is 191 mg/dL, FBG 112.5 mg/dL, 2hPPBG 134.5 mg/dL, HDL 44.9 mg/dL, LDL 137.5 mg/dL, ureum 27 mg/dL, and creatinin 0.8 mg/dL. The proportion of Diabetes Mellitus patients in this study is 50% and hypertension 57.5%, which is 15% of them belong to mild erectile dysfunction category, 37.5% mild to moderate, 5% moderate, and 42.5% severe. We found an increasement of EHS on 75% patients that were treated with ESWT and 5% on patient that were treated with Tadalafil, and it is statistically significant (p<0.05). Conclusion: We found that ESWT and Tadalafil can increase EHS of organic erectile dysfunction patients, which ESWT is more effective than Tadalafil.
Placenta Percreta With Bladder Involvement Zulfiqar, Yefri
Journal of Midwifery Vol 9, No 1 (2024): Published on June 2024
Publisher : Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jom.9.1.72-74.2024

Abstract

Placenta accreta spectrum (PAS) is characterized by abnormal placental invasion due to incomplete or complete loss of decidua. PAS subtypes are classified based on the depth of invasion: placenta accreta, increta, and percreta. Placenta percreta is the most severe form of placenta accreta and is characterized by invasion of the placenta through the entire myometrium reaching up to the uterine serosa. The increasing rate of placenta accrete because of increased rate of cesarean delivery. Urological complications are relatively rare in placenta accreta spectrum (PAS), but can be severe. Treatment planning must always involve a multidisciplinary team. Placenta percreta is a very high-risk obstetric condition associated with morbidity and mortality. A 32-year-old woman referred from Maternal Fetal Medicine Polyclinic with G4P2A1L2 37-38 weeks of term pregnancy + total placenta previa suspected percreta PAS 2 grade 3B S2 + once previous CS, and a CCS hysterectomy was planned. PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift artifacts in the steady-state free precession sequence and abnormal vascularization at the uterovesical interface on USG (Ultrasonography)
Placenta Percreta with Massive Hematuria Zulfiqar, Yefri
Journal of Midwifery Vol 9, No 1 (2024): Published on June 2024
Publisher : Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jom.9.1.48-51.2024

Abstract

Placenta accreta spectrum disorder (PAS) is diagnosed clinically when the placenta cannot be separated from the uterus after delivery. Abnormal placentas can be classified into three different entities such as placenta accreta, increta, and percreta. Placenta percreta is rare. Bladder bleeding due to placenta percreta has a poor prognosis. The main peculiarities of our case were a history of previous cesarean section, uterine curettage for miscarriage, and multiparity. Hematuria occurred in only 5% of patients. Early detection and appropriate treatment can save the patient's life
Co-Authors Anak Agung Istri Sri Wiadnyani Etriyel Myh Wiradinata, Indra